H30122 - Department of Computer and Information Sciences

The Center for Information Assurance and Joint Forensics Research (Center) and the Department of Computer and Information Sciences (CIS) seek highly competitive postdoctoral candidates to apply for position(s) to be filled as soon as possible with a start date of January 1, 2013.  Information about the Center can be found at http://thecenter.uab.edu

The Center for Information Assurance and Joint Forensics Research (Center) and the Department of Computer and Information Sciences (CIS) seek highly competitive postdoctoral candidates to apply for position(s) to be filled as soon as possible with a start date of January 1, 2013.  Information about the Center can be found at http://thecenter.uab.edu

Qualifications:  An earned degree in Computer Science, Computer Engineering, or closely related fields.   Strong publishing, proposal development, and new concept development are expected. 

Areas of interest:  Computer Forensics, Cyber Crime, Data Mining, Machine Learning, and related areas. 

Position duties and responsibilities:  The successful candidate will pursue R&D in cyber, email related crime studies (SPAM, phishing), malware, and integrative projects in the Center with internal colleagues and externally funded efforts.  Teaching 1 or 2 courses per year consistent with career development will be required. The candidate will have significant opportunities for professional development, mentoring, and integration into state-of-the-art areas for cyber, crime, forensics, and big data sciences associated therewith. 

Term of position:  The initial term of appointment will be two years with the opportunity for renewal annually.

Applicants should submit a detailed CV indicating education, publications, research experience, and citizenship/visa status via email only to Dr. Anthony Skjellum, Center Director – This email address is being protected from spambots. You need JavaScript enabled to view it. .

US citizenship is required for a specific DARPA-funded project but all qualified candidates are encouraged to apply.

Consideration of all applications will continue until the position is filled. A pre-employment background investigation is performed on the candidate(s) selected for employment.  The University of Alabama at Birmingham is an Equal Opportunity/Affirmative Action Employer and encourages applications from qualified women and minorities.

UAB News

  • Bluesman Keb’ Mo’ will take the stage first at 7 p.m., with alternative hip-hop  rockers G. Love & Special Sauce performing the second set.Keb' Mo'The University of Alabama at Birmingham’s Alys Stephens Performing Arts Center will present Keb’ Mo’ and G. Love & Special Sauce on Tuesday, Aug. 26. The two bands will perform as co-headliners; each will perform a separate set, with Keb’ Mo’ first. The show is set for 7 p.m., in the ASC,...

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...

UAB Research News

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...